Gain Therapeutics, Inc. (GANX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Accumulate

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

0

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Apr-24 4:01 PM View:	28-Mar-24 Private Purchase $115.77K	Riley Jeffrey Scott Director		Gain Therapeutics, Inc. - GANX	100% 0 to 30.0K	0	0	--	--	Show Txns Hide Txns

01-Jul-24 5:00 PM View:	01-Jul-24 Private Purchase $20.67K	Richman Eric I Director		Gain Therapeutics, Inc. - GANX	6% 287.46K to 304.46K	0	0	--	--	Show Txns Hide Txns

28-Mar-24 9:00 PM View:	26-Mar-24 Payment of Exercise ($24.71K)	Alder Matthias Chief Executive Officer Director		Gain Therapeutics, Inc. - GANX	217% 6.67K to 21.14K	0	0	--	--	Show Txns Hide Txns

12-Aug-24 5:23 PM View:	09-Aug-24 Private Purchase $14.54K	MacK Gene CFO and Interim CEO		Gain Therapeutics, Inc. - GANX	100% 0 to 14.4K	0	0	--	--	Show Txns Hide Txns

12-Aug-24 5:23 PM View:	09-Aug-24 Private Purchase $49.94K	Islam Khalid Executive Chairman Director		Gain Therapeutics, Inc. - GANX	6% 880.78K to 930.78K	0	0	--	--	Show Txns Hide Txns